Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when ...

AIDS Resource Alliance Inc. was recently selected as a second-year grant awardee of the AstraZeneca Foundation’s Creating Health Access for Next Generation Equity (CHANGE) program, which aims to ...

Kyverna Therapeutics, Inc. (Kyverna), a clinical-stage biopharmaceutical company focused on developing cell therapies for ...

Move over, AI. There's another fast-moving technology that's expected to generate massive financial gains in the second half of the 2020s. Quantum computing's reputation is growing as a tech ...

NEW YORK, NY / ACCESSWIRE / December 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of AstraZeneca PLC ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

SAN ANTONIO -- Endocrine therapy after breast-conserving surgery was associated with worse health-related quality of life ...

Action is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers ...

We recently compiled a list of the 11 Best Computer Hardware Stocks to Invest in Right Now. In this article, we are going to ...

Omitting axillary SLNB does not impact outcomes in patients with early invasive breast cancer undergoing breast-conserving surgery, data suggest.

AstraZeneca PLC AZN shares inched down 0.95% to £104.68 Friday, on what proved to be an all-around grim trading session for ...

The Dragons' Den star's podcast is increasingly focused on bizarre medical advice that could lead to ill health in those who ...